Quartesian
Quartesian is a clinical data solutions company providing Electronic Data Capture implementation, clinical data management, biostatistics, and medical writing services to biopharmaceutical and medical device sponsors, now operating as the 'EDC & Data Solutions' subsidiary of Veranex.
- Company typePrivate
- Founded2003
- HeadquartersNewtown, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Quartesian does
Quartesian is a clinical data solutions company that provides Electronic Data Capture (EDC) technology implementation, clinical data management, biostatistics and programming, and medical writing services to biopharmaceutical and medical device sponsors conducting clinical trials. The company's service offering centers on deploying EDC systems — built on over eight years of working experience with Medidata's clinical data technology platform — to capture, clean, validate, and transform trial data into audit-ready datasets, alongside developing standardized global EDC library templates that allow sponsors to standardize clinical data architecture across programs and geographies.
Quartesian sells primarily into two vertical end markets — biopharmaceutical companies running clinical trials and medical device companies preparing regulatory submissions — addressing pain points around legacy process modernization, faster data cleaning, and improved data quality at what the company positions as affordable rates. Its go-to-market is direct enterprise sales executed through project-based professional services engagements, with no public pricing disclosed.
Quartesian was founded and operated as an independent EDC-focused CRO before being acquired by Veranex in 2024. It now operates as a wholly-owned subsidiary under Veranex's 'EDC & Data Solutions' branding, embedded within Veranex's integrated medtech CRO platform that spans trial design, trial management, data management, biostatistics, medical writing, regulatory, quality, and commercialization consulting across medtech categories including cardiovascular, neurology, ophthalmology, and in-vitro diagnostics. The company is headquartered in Newtown, United States, with a flexible global delivery footprint and 101-250 employees.
Quartesian firmographics
Firmographics- Name
- Quartesian
- Legal name
- Quartesian
- Website
- https://quartesian.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Quartesian is a clinical data solutions company providing Electronic Data Capture implementation, clinical data management, biostatistics, and medical writing services to biopharmaceutical and medical device sponsors, now operating as the 'EDC & Data Solutions' subsidiary of Veranex.
- Ownership category
- akta.pro rank
Where Quartesian is headquartered
LocationHeadquarters
- HQ city
- Newtown
- HQ country
- United States
- HQ region
- North America
Markets served
Quartesian business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Clinical Data Solutions Services: Professional services revenue generated through clinical data management, EDC technology implementation, and clinical data solutions for biopharmaceutical and medical device companies.
Go-to-market motion1 record
Distribution channels1 record
Quartesian product offering
Product offeringCore offering
Quartesian is a clinical data solutions company that delivers Electronic Data Capture (EDC) technology and clinical data management services for clinical trials, including biostatistics, programming, and medical writing. The firm operates as a contract research organization (CRO) with a flexible global footprint, modernizing legacy clinical processes and standardizing clinical data architecture for biopharmaceutical and medical device sponsors.
Product overview
Quartesian is a clinical data solutions company specializing in Electronic Data Capture (EDC) technology and clinical data management services. The company offers a unified platform for EDC with associated data management and biostatistics services. Quartesian's core offering centers on EDC technology that bridges the gap between legacy clinical processes and digital environments, providing clean data faster to improve analysis speed and data quality while developing global EDC library standards. The company operated for over eight years with Medidata clinical data technology solutions before being acquired by Veranex.
Differentiator
Problem solved
Functional benefit
Products and services
- Electronic Data Capture (EDC) Services Implementation and operation of EDC technology for clinical trials, including upgrading legacy clinical processes to modern EDC platforms. Targeted at biopharmaceutical and medical device sponsors running clinical studies.
- Clinical Data Management Services End-to-end clinical data management for clinical trials, producing clean, standardized clinical data architecture. Targeted at clinical trial sponsors in biopharma and medical device industries.
- Biostatistics & Programming Services Biostatistics and programming support for clinical trials, including analysis datasets, statistical outputs, and regulatory-grade deliverables. Targeted at clinical trial sponsors requiring statistical analysis.
- Medical Writing Services Medical writing support for clinical study reports, regulatory submissions, and related clinical documentation. Targeted at biopharmaceutical and medical device sponsors preparing regulatory filings.
Companies that use Quartesian
Customer profileSegments2 records
Ideal customer profiles1 record
Quartesian technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Quartesian partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MedidatacoreQuartesian worked with Medidata clinical data technology solutions for over eight years, building expertise in EDC technology implementation and clinical data management using Medidata's platform. This partnership enabled Quartesian to deliver high quality clinical data solutions to biopharmaceutical and medical device clients.
Scale indicators1 record
Recent moves4 records
Expansion highlights4 records
Quartesian competitors and assessment
Company assessmentDirect peers
- Medidata Solutions (Dassault Systèmes): Medidata is the leading EDC platform provider whose Rave Clinical Cloud forms the backbone of most modern clinical trials. Quartesian has built 8+ years of Medidata implementation expertise, making Medidata the closest upstream/peer technology provider competing for sponsor mind share on clinical data capture.
- Veeva Systems: Veeva's CDB (Clinical Data Base) and Vault EDC platform competes directly with Medidata Rave in the clinical data capture market. As Quartesian services Medidata-based trials, Veeva represents the alternative EDC ecosystem where similar data management and biostatistics services are demanded.
- Signant Health (formerly CRF Bracket / Bioclinica): Signant Health specializes in clinical trial technology services including EDC implementation, data management, and biostatistics for pharma and medical device sponsors. Directly comparable niche CRO/service provider focused on clinical data capture and trial enablement.
- Bioforum Bio-Médical-Audit SARL: Bioforum is a specialized CRO focused on clinical data management, biostatistics, and EDC implementation—essentially a direct competitive mirror of Quartesian's offering. Comparable size and scope make it one of the closest specialized peers.
- Celerion: Celerion is a CRO specializing in early-phase clinical research including clinical data management and biostatistics services. Comparable niche-focused CRO competing for outsourced biopharmaceutical data work.
Broad incumbents
- Oracle Health Sciences (Clinical One): Oracle's Clinical One platform and broader Health Sciences suite provide EDC, clinical data management, and analytics for trial sponsors, overlapping with Quartesian's core offerings. Oracle is a broader incumbent serving pharma and CROs with both platform and analytics layers.
- Parexel International: Parexel is a top-5 global CRO offering full clinical trial services including biostatistics, data management, and medical writing for pharma/biotech. Represents the broader incumbent against which Quartesian competes as a focused data-management specialist.
- IQVIA: IQVIA is the largest global CRO with extensive in-house biostatistics, data management, and EDC services. As a broad incumbent with proprietary technology platforms, IQVIA competes with Quartesian for outsourced clinical data work.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering clinical data management, biostatistics, and trial execution services. Provides broader-scope competition for Quartesian's specialized data services.
Emerging players
- ArisGlobal: ArisGlobal provides life sciences R&D platforms including clinical trial management and safety solutions. Its platform competes in adjacent clinical data and trial enablement where Quartesian's EDC and biostatistics services operate.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Quartesian social profiles
Digital presenceQuartesian financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quartesian leadership team
Management profileNumber of profiles
Profiles2 records
Quartesian funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quartesian M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quartesian
What does Quartesian do?
Quartesian is a clinical data solutions company that delivers Electronic Data Capture (EDC) technology and clinical data management services for clinical trials, including biostatistics, programming, and medical writing. The firm operates as a contract research organization (CRO) with a flexible global footprint, modernizing legacy clinical processes and standardizing clinical data architecture for biopharmaceutical and medical device sponsors.
Is Quartesian a public or private company?
Quartesian is a private company. It is classified as corporate owned and is currently acquired.
When was Quartesian founded?
Quartesian was founded in 2003. It employs 101 to 250 people.
Where is Quartesian based?
Quartesian is headquartered in Newtown, United States, in the North America region.
How does Quartesian make money?
One revenue line is on record: clinical Data Solutions Services.
Who are Quartesian's main competitors?
Direct peers on record are Medidata Solutions (Dassault Systèmes), Veeva Systems, Signant Health (formerly CRF Bracket / Bioclinica), Bioforum Bio-Médical-Audit SARL and Celerion. Broad incumbents are Oracle Health Sciences (Clinical One), Parexel International, IQVIA and Worldwide Clinical Trials. ArisGlobal is listed as an emerging player.
Does Quartesian have an API?
No public API is recorded for Quartesian.